Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-09964-6, published online 13 April 2022
In the original version of this Article, the approval number for the PBMC isolation was incorrect.
As a result, In the Methods section, under the subheading ‘Peripheral blood mononuclear cell (PBMC) isolation and culture’
“PBMC isolation was performed according to the guidelines of both the Declaration of Helsinki and the Siriraj Institutional Review Board (SIRB) of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (approval no. Si 517/2018).”
now reads:
“PBMC isolation was performed according to the guidelines of both the Declaration of Helsinki and the Siriraj Institutional Review Board (SIRB) of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (approval no. Si 517/2016).”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wathikthinnakon, M., Luangwattananun, P., Sawasdee, N. et al. Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells. Sci Rep 15, 4515 (2025). https://doi.org/10.1038/s41598-025-88644-7
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-88644-7
